Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|11|1154-1160

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.11, 2015-11, pp. : 1154-1160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of anti‐TNF therapy in elderly patients with inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 4, 2015-08 ,pp. : 441-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changing face of care for patients with moderate to severe inflammatory bowel disease: the role of specialist nurses in the governance of anti‐TNF prescribing

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1161-1166

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications—authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 448-448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti‐TNF medications

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 446-447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 613-623

John Wiley & Sons Inc

Access to resources Recommend Favorite